Diabetes Care Devices Market: Growth, Size, Share, and Trends

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 16)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 21)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Key data from primary sources
                    2.1.2.2 Breakdown of primary sources
    2.2 MARKET SIZE ESTIMATION
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 32)

4 PREMIUM INSIGHTS (Page No. - 35)
    4.1 DIABETES CARE DEVICES MARKET OVERVIEW
    4.2 DIABETES CARE DEVICES (BRIC) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    4.3 DIABETES CARE DEVICES (BRIC) MARKET: COUNTRY MIX (2020–2025)

5 INDUSTRY INSIGHTS (Page No. - 38)
    5.1 INDUSTRY TRENDS
           5.1.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
           5.1.2 SMART GLUCOSE METERS ENABLE INTEGRATED DIABETES MANAGEMENT SOLUTIONS
           5.1.3 SMART INSULIN PEN SYNCHRONIZATION WITH GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING
           5.1.4 INNOVATIVE INSULIN DELIVERY SYSTEMS
    5.2 REGULATORY ANALYSIS
           5.2.1 CHINA
           5.2.2 INDIA
           5.2.3 BRAZIL
           5.2.4 RUSSIA
    5.3 COVID-19 IMPACT ON THE DIABETES CARE DEVICES (BRIC) MARKET

6 DIABETES CARE DEVICES MARKET, BY TYPE (Page No. - 46)
    6.1 INTRODUCTION
    6.2 BLOOD GLUCOSE MONITORING SYSTEMS
           6.2.1 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS
                    6.2.1.1 Technological innovations to drive the growth of self-monitoring blood glucose monitoring systems
           6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS
                    6.2.2.1 Increasing collaborations, partnerships, and agreements between companies to develop integrated CGM systems to drive the growth of this market
           6.2.3 TEST STRIPS/TEST PAPERS
                    6.2.3.1 Shift toward non-invasive methods for blood glucose monitoring to restrain the growth of this market during the forecast period
           6.2.4 LANCETS/LANCING DEVICES
                    6.2.4.1 Rising focus to reduce the chances of infection and accidental pricking to increase the popularity of safety lancets during the forecast period
    6.3 INSULIN DELIVERY DEVICES
           6.3.1 INSULIN PUMPS
                    6.3.1.1 Insulin pumps integrated with continuous glucose monitoring systems offer the benefits of data integration and diabetes management
           6.3.2 INSULIN PENS
                    6.3.2.1 The convenience of use of insulin pens and increasing affordability could drive the growth of this segment during the forecast period
           6.3.3 INSULIN SYRINGES AND NEEDLES
                    6.3.3.1 Safety concerns and increasing awareness of affordable alternatives in the market could restrain the growth of this segment during the forecast period
    6.4 DIABETES MANAGEMENT MOBILE APPLICATIONS
           6.4.1 GROWING ADOPTION OF BLOOD GLUCOSE TRACKING APPS AND INCREASING AWARENESS OF DIABETES AMONG PATIENTS TO DRIVE MARKET GROWTH

7 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS (Page No. - 69)
    7.1 INTRODUCTION
    7.2 SELF/HOME HEALTHCARE
           7.2.1 INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES HAS FUELED THE PREFERENCE FOR SELF/HOME HEALTHCARE
    7.3 HOSPITALS & DIABETES SPECIALTY CLINICS
           7.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS BOOSTS THE MARKET GROWTH

8 DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES (Page No. - 73)
    8.1 INTRODUCTION
    8.2 CHINA: MARKET
           8.2.1 INTRODUCTION
           8.2.2 MARKET DRIVERS
                    8.2.2.1 Sharp increase in diabetes in the past decade
                    8.2.2.2 Favorable national health strategies
                    8.2.2.3 Government-LED endorsement of the medical device industry
           8.2.3 MARKET RESTRAINTS
                    8.2.3.1 Traditional Chinese medicine as an alternative
                    8.2.3.2 High cost of advanced diabetes management devices
           8.2.4 MARKET OPPORTUNITIES
                    8.2.4.1 Significant advancements and leveraging of artificial intelligence and big data
           8.2.5 MARKET CHALLENGES
                    8.2.5.1 Lack of adherence of patients to recommended diabetes treatment guidelines
    8.3 INDIA: MARKET
           8.3.1 INTRODUCTION
           8.3.2 MARKET DRIVERS
                    8.3.2.1 High prevalence of diabetes
                    8.3.2.2 Government’s “Make in India” campaign to encourage local manufacturing of medical devices
                    8.3.2.3 Diabetes awareness campaigns and screening camps
           8.3.3 MARKET RESTRAINTS
                    8.3.3.1 Lack of accessibility to healthcare
                    8.3.3.2 Inadequate health insurance coverage
           8.3.4 MARKET OPPORTUNITIES
                    8.3.4.1 Rising adoption of Mhealth
           8.3.5 MARKET CHALLENGES
                    8.3.5.1 Shortage of healthcare professionals in diabetes management
    8.4 BRAZIL: MARKET
           8.4.1 INTRODUCTION
           8.4.2 MARKET DRIVERS
                    8.4.2.1 High prevalence of diabetes
                    8.4.2.2 Favorable government policies
           8.4.3 MARKET RESTRAINTS
                    8.4.3.1 Lack of awareness of diabetes care
                    8.4.3.2 High prices of advanced diabetes care devices
           8.4.4 MARKET OPPORTUNITIES
                    8.4.4.1 Increasing penetration of smartphones and rising focus on digital health to drive the growth of diabetes management platforms and diabetes management mobile applications
           8.4.5 MARKET CHALLENGES
                    8.4.5.1 Strict regulatory guidelines and regulatory process for medical devices
    8.5 RUSSIA: MARKET
           8.5.1 INTRODUCTION
           8.5.2 MARKET DRIVERS
                    8.5.2.1 Rising elderly population
                    8.5.2.2 Increasing rate of obesity
           8.5.3 MARKET RESTRAINTS
                    8.5.3.1 Large number of undiagnosed diabetics
           8.5.4 MARKET OPPORTUNITIES
                    8.5.4.1 Government spending on healthcare
                    8.5.4.2 Rising investment of pharma market players to establish local manufacturing plants
           8.5.5 MARKET CHALLENGES
                    8.5.5.1 Low adoption of glucose monitoring systems

9 COMPETITIVE LANDSCAPE (Page No. - 100)
    9.1 OVERVIEW
    9.2 PRODUCT BENCHMARKING
    9.3 GEOGRAPHIC REACH OF THE TOP MARKET PLAYERS (2019)
    9.4 R&D EXPENDITURE: KEY PLAYERS IN THE DIABETES CARE DEVICES (BRIC) MARKET
    9.5 MARKET SHARE ANALYSIS
           9.5.1 BRAZIL: MARKET SHARE ANALYSIS
           9.5.2 RUSSIA: MARKET SHARE ANALYSIS
           9.5.3 INDIA: MARKET SHARE ANALYSIS
           9.5.4 CHINA: MARKET SHARE ANALYSIS
    9.6 COMPETITIVE SITUATION AND TRENDS
           9.6.1 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
           9.6.2 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES

10 COMPANY PROFILES (Page No. - 115)
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
     10.1 F. HOFFMAN-LA ROCHE LTD.
     10.2 ABBOTT
     10.3 ASCENSIA DIABETES CARE HOLDINGS AG
     10.4 DEXCOM, INC.
     10.5 MEDTRONIC PLC
     10.6 B. BRAUN MELSUNGEN AG
     10.7 BECTON, DICKINSON AND COMPANY
     10.8 ACON LABORATORIES, INC.
     10.9 ARKRAY, INC.
     10.10 SANOFI
     10.11 NOVO NORDISK A/S
     10.12 TERUMO CORPORATION
     10.13 YPSOMED
     10.14 SINOCARE, INC.
     10.15 AGAMATRIX HOLDINGS LLC
     10.16 LIFESCAN
     10.17 SD BIOSENSOR, INC.
     10.18 MICROGENE DIAGNOSTIC SYSTEMS PVT. LTD.
     10.19 DR. MOREPEN
     10.20 BIONIME CORPORATION
     10.21 ROSSMAX INTERNATIONAL LTD.

*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.

11 APPENDIX (Page No. - 161)
     11.1 INSIGHTS OF INDUSTRY EXPERTS
     11.2 DISCUSSION GUIDE
     11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.4 AVAILABLE CUSTOMIZATIONS
     11.5 RELATED REPORTS
     11.6 AUTHOR DETAILS

LIST OF TABLES (64 TABLES)

TABLE 1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE DIABETES CARE DEVICES MARKET
TABLE 2 EXCHANGE RATES UTILIZED FOR USD CONVERSION
TABLE 3 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
TABLE 4 MAJOR SMART GLUCOSE METERS AVAILABLE GLOBALLY
TABLE 5 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES IN BRIC COUNTRIES
TABLE 7 CHINA: MEDICAL DEVICE CLASSIFICATION
TABLE 8 INDIA: MEDICAL DEVICE CLASSIFICATION
TABLE 9 BRAZIL: MEDICAL DEVICE CLASSIFICATION
TABLE 10 RUSSIA: MEDICAL DEVICE CLASSIFICATION
TABLE 11 AVERAGE SELLING PRICE ANALYSIS OF DIABETES CARE DEVICES (BRIC MARKET)
TABLE 12 GLOBAL MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 13 GLOBAL MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 18 MAJOR SELF-MONITORING BLOOD GLUCOSE METERS AVAILABLE IN BRIC COUNTRIES
TABLE 19 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 21 MAJOR CONTINUOUS GLUCOSE MONITORING SYSTEMS AVAILABLE IN BRIC COUNTRIES
TABLE 22 TEST STRIPS/TEST PAPERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 23 TEST STRIPS/TEST PAPERS (100 STRIPS) MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 24 MAJOR TEST STRIPS/TEST PAPERS AVAILABLE IN BRIC COUNTRIES
TABLE 25 LANCETS/LANCING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 LANCETS (PER 100) & LANCING DEVICES (PER UNIT) MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 27 MAJOR LANCETS/LANCING DEVICES AVAILABLE IN BRIC COUNTRIES
TABLE 28 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 29 INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 30 INSULIN PUMPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 INSULIN PUMPS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 32 MAJOR INSULIN PUMPS AVAILABLE IN BRIC COUNTRIES
TABLE 33 INSULIN PENS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 INSULIN PENS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 35 MAJOR INSULIN PENS AVAILABLE IN BRIC COUNTRIES
TABLE 36 INSULIN SYRINGES AND NEEDLES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 37 INSULIN SYRINGES AND NEEDLES (PER 100) MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS)
TABLE 38 INSULIN SYRINGES AND NEEDLES AVAILABLE IN BRIC COUNTRIES
TABLE 39 DIABETES MANAGEMENT MOBILE APPLICATIONS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 40 MAJOR DIABETES MANAGEMENT APPLICATIONS AVAILABLE IN BRIC COUNTRIES
TABLE 41 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 42 GLOBAL MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 43 GLOBAL MARKET FOR HOSPITAL & DIABETES SPECIALTY CLINICS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 44 CHINA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 45 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 46 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 47 CHINA: MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 48 INDIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 49 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 INDIA: MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 52 BRAZIL: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 53 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 55 BRAZIL: MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 56 RUSSIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 RUSSIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 58 RUSSIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 59 RUSSIA: MARKET, BY PATIENT CARE SETTINGS, 2018–2025 (USD MILLION)
TABLE 60 MARKET EVALUATION MATRIX (2018–2020)
TABLE 61 BRAZIL: MARKET RANKING, BY KEY PLAYER, 2019
TABLE 62 RUSSIA: MARKET RANKING, BY KEY PLAYER, 2019
TABLE 63 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2019-2020)
TABLE 64 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES (2019)

LIST OF FIGURES (42 FIGURES)

FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRY
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 DIABETES CARE DEVICES (BRIC) MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 9 SELF/HOME HEALTHCARE WILL DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE DIABETES CARE DEVICES (BRIC) MARKET
FIGURE 11 INCREASING PREVALENCE OF DIABETES AND THE GROWING DEMAND FOR NON-INVASIVE GLUCOSE MONITORING AND DIGITAL DIABETES SOLUTIONS DRIVE THE GROWTH OF THE MARKET
FIGURE 12 INDIA TO REGISTER THE FASTEST GROWTH IN THE DIABETES CARE DEVICES (BRIC) MARKET DURING THE FORECAST PERIOD
FIGURE 13 BRAZIL TO WITNESS THE SECOND-FASTEST GROWTH DURING THE FORECAST PERIOD (2020–2025)
FIGURE 14 GEOGRAPHIC SNAPSHOT: DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES
FIGURE 15 NUMBER OF ADULT DIABETICS IN CHINA (MILLION)
FIGURE 16 CHINA: MARKET SNAPSHOT
FIGURE 17 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (0-14 YEARS) IN 2019
FIGURE 18 INDIA: MARKET SNAPSHOT
FIGURE 19 YEAR-ON-YEAR DIABETES PREVALENCE (BRAZIL)
FIGURE 20 BRAZIL: DIABETES CARE DEVICE MARKET SNAPSHOT
FIGURE 21 POPULATION AGED ABOVE 65 YEARS AS A PERCENTAGE OF TOTAL POPULATION (RUSSIA)
FIGURE 22 RUSSIA: MARKET SNAPSHOT
FIGURE 23 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2018 AND MAY 2020
FIGURE 24 PRODUCT PORTFOLIO ANALYSIS: GLOBAL MARKET
FIGURE 25 DOMESTIC AND FOREIGN PLAYERS IN THE BRAZILIAN MARKET
FIGURE 26 DOMESTIC AND FOREIGN PLAYERS IN THE RUSSIAN MARKET
FIGURE 27 DOMESTIC AND FOREIGN PLAYERS IN THE INDIAN MARKET
FIGURE 28 INDIA: GLOBAL MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 29 DOMESTIC & FOREIGN PLAYERS IN THE CHINESE DIABETES CARE DEVICES MARKET
FIGURE 30 CHINA: DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 31 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MAJOR PLAYERS BETWEEN 2018 AND 2020
FIGURE 32 F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT (2019)
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2019)
FIGURE 34 DEXCOM, INC.: COMPANY SNAPSHOT (2019)
FIGURE 35 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019)
FIGURE 38 SANOFI: COMPANY SNAPSHOT (2019)
FIGURE 39 NOVO NORDISK A/S: COMPANY SNAPSHOT (2019)
FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2019)
FIGURE 41 YPSOMED: COMPANY SNAPSHOT (2019)
FIGURE 42 SINOCARE, INC.: COMPANY SNAPSHOT (2019)